Exact Sciences Corporation (EXAS) analyst actions
Rating and price-target actions on EXAS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the EXAS overview →
No EXAS analyst action events in the measured window.
Nothing matched in the current window — the EXAS overview has every event we measure for this name.
Get an email when EXAS moves on news →Keep exploring
More EXAS: earnings → · SEC filings → · EXAS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) | 438 | 0.00% | 50% |
| Zymeworks Inc. (ZYME) | 438 | 0.00% | 50% |
| IMMUNE PHARMACEUTICALS INC NE (IMNP) | 437 | -0.77% | 36% |
| Intec Pharma Ltd (NTEC) | 437 | -0.26% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.